Prolonged activation of cytomegalovirus early gene e1-promoter exclusively in neurons during infection of the developing cerebrum.
Animals
Antigens, Viral
/ genetics
Cells, Cultured
Central Nervous System Viral Diseases
/ congenital
Cerebrum
/ growth & development
Cytomegalovirus Infections
/ pathology
Disease Models, Animal
Mice
Mice, Transgenic
Muromegalovirus
/ genetics
Neuroglia
/ immunology
Neurons
/ immunology
Promoter Regions, Genetic
Time Factors
Tissue Distribution
Cerebral neuron
Congenital infection
Cytomegalovirus
Neurodevelopmental disorder
Persistent infection
e1-promoter
Journal
Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673
Informations de publication
Date de publication:
09 03 2021
09 03 2021
Historique:
received:
10
01
2021
accepted:
26
02
2021
entrez:
22
3
2021
pubmed:
23
3
2021
medline:
19
11
2021
Statut:
epublish
Résumé
The brain is the major target of congenital cytomegalovirus (CMV) infection. It is possible that neuron disorder in the developing brain is a critical factor in the development of neuropsychiatric diseases in later life. Previous studies using mouse model of murine CMV (MCMV) infection demonstrated that the viral early antigen (E1 as a product of e1 gene) persists in the postnatal neurons of the hippocampus (HP) and cerebral cortex (CX) after the disappearance of lytic infection from non-neuronal cells in the periventricular (PV) region. Furthermore, neuron-specific activation of the MCMV-e1-promoter (e1-pro) was found in the cerebrum of transgenic mice carrying the e1-pro-lacZ reporter construct. In this study, in order to elucidate the mechanisms of e1-pro activation in cerebral neurons during actual MCMV infection, we have generated the recombinant MCMV (rMCMV) carrying long e1-pro1373- or short e1-pro448-EGFP reporter constructs. The length of the former, 1373 nucleotides (nt), is similar to that of transgenic mice. rMCMVs and wild type MCMV did not significantly differed in terms of viral replication or E1 expression. rMCMV-infected mouse embryonic fibroblasts showed lytic infection and activation of both promoters, while virus-infected cerebral neurons in primary neuronal cultures demonstrated the non-lytic and persistent infection as well as the activation of e1-pro-1373, but not -448. In the rMCMV-infected postnatal cerebrum, lytic infection and the activation of both promoters were found in non-neuronal cells of the PV region until postnatal 8 days (P8), but these disappeared at P12, while the activation of e1-pro-1373, but not -448 appeared in HP and CX neurons at P8 and were prolonged exclusively in these neurons at P12, with preservation of the neuronal morphology. Therefore, e1-pro-448 is sufficient to activate E1 expression in non-neuronal cells, however, the upstream sequence from nt -449 to -1373 in e1-pro-1373 is supposed to work as an enhancer necessary for the neuron-specific activation of e1-pro, particularly around the second postnatal week. This unique activation of e1-pro in developing cerebral neurons may be an important factor in the neurodevelopmental disorders induced by congenital CMV infection.
Identifiants
pubmed: 33750455
doi: 10.1186/s40478-021-01139-0
pii: 10.1186/s40478-021-01139-0
pmc: PMC7941713
doi:
Substances chimiques
Antigens, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
39Références
J Virol. 2013 Mar;87(5):2639-47
pubmed: 23255797
J Neurosci. 2013 Apr 24;33(17):7368-83
pubmed: 23616543
Neuroscience. 2001;105(1):7-17
pubmed: 11483296
Trends Neurosci. 2006 Jul;29(7):398-406
pubmed: 16806513
J Virol. 1984 Jul;51(1):117-22
pubmed: 6202880
N Engl J Med. 1992 Mar 5;326(10):663-7
pubmed: 1310525
Mol Psychiatry. 2014 Mar;19(3):325-33
pubmed: 23358160
J Infect Dis. 1989 Mar;159(3):384-9
pubmed: 2644376
J Virol. 2006 Sep;80(18):8929-39
pubmed: 16940505
Virology. 1995 May 10;209(1):236-41
pubmed: 7747475
Ann Neurol. 1992 Jan;31(1):64-8
pubmed: 1311911
Am J Pathol. 2002 Sep;161(3):919-28
pubmed: 12213720
J Neurosci. 2006 Jan 4;26(1):345-53
pubmed: 16399705
Intervirology. 1997;40(2-3):85-97
pubmed: 9450226
Virology. 1996 Jun 15;220(2):508-15
pubmed: 8661403
J Virol. 1990 May;64(5):1907-19
pubmed: 2157860
J Virol. 1994 Jul;68(7):4117-25
pubmed: 8207790
Cell Host Microbe. 2010 Apr 22;7(4):302-13
pubmed: 20413098
J Virol. 1992 Jan;66(1):27-36
pubmed: 1309246
J Virol. 2016 Apr 14;90(9):4626-4636
pubmed: 26912612
J Gen Virol. 2010 Nov;91(Pt 11):2664-76
pubmed: 20631086
J Virol. 1994 Sep;68(9):5613-22
pubmed: 8057441
Acta Neuropathol. 1998 Sep;96(3):239-47
pubmed: 9754956
J Virol. 1989 Jul;63(7):3117-27
pubmed: 2542619
Transl Psychiatry. 2015 Feb 03;5:e502
pubmed: 25646591
Acta Neuropathol. 2005 May;109(5):475-82
pubmed: 15759129
Perspect Pediatr Pathol. 1981;6:203-41
pubmed: 6275339
J Virol. 2008 Oct;82(20):9994-10007
pubmed: 18684829
Virus Res. 2011 May;157(2):144-50
pubmed: 20969904
Schizophr Bull. 2009 Nov;35(6):1163-82
pubmed: 18552348
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8862-7
pubmed: 11438693
Acta Neuropathol. 1989;79(3):262-70
pubmed: 2558485
J Virol. 2018 May 14;92(11):
pubmed: 29540598
Proc Soc Exp Biol Med. 1970 Nov;135(2):253-8
pubmed: 4320336
J Virol. 2002 Sep;76(18):9493-504
pubmed: 12186931
Sci Rep. 2019 Mar 25;9(1):5037
pubmed: 30911152
J Neurosci. 1999 Dec 15;19(24):10948-65
pubmed: 10594076
Rev Med Virol. 2005 Sep-Oct;15(5):327-45
pubmed: 16100703
Pediatrics. 1986 Jun;77(6):801-6
pubmed: 3012452
Nat Rev Mol Cell Biol. 2020 Oct;21(10):571-584
pubmed: 32636524
Int J Clin Exp Pathol. 2018 Jan 01;11(1):129-137
pubmed: 31938094
Cell Mol Immunol. 2015 Mar;12(2):180-91
pubmed: 25042632
Clin Microbiol Rev. 2009 Jan;22(1):99-126, Table of Contents
pubmed: 19136436
Arch Virol. 2006 Nov;151(11):2181-96
pubmed: 16755372
J Neuropathol Exp Neurol. 2014 Feb;73(2):143-58
pubmed: 24423639
Am J Pathol. 2003 Aug;163(2):643-52
pubmed: 12875983
Ann Clin Transl Neurol. 2014 Aug;1(8):570-88
pubmed: 25356429
Nat Rev Immunol. 2002 Nov;2(11):831-44
pubmed: 12415307
Lab Invest. 2000 Sep;80(9):1373-83
pubmed: 11005206
Ann Neurol. 2012 Apr;71(4):444-57
pubmed: 22334391
J Virol. 1996 Dec;70(12):8833-49
pubmed: 8971012
Front Behav Neurosci. 2009 Aug 24;3:14
pubmed: 19738918
J Virol. 1999 Dec;73(12):10458-71
pubmed: 10559364
Am J Pathol. 1987 May;127(2):262-70
pubmed: 3034066
Front Neuroanat. 2011 Feb 17;5:5
pubmed: 21369363
Am J Pathol. 1997 Nov;151(5):1331-40
pubmed: 9358759
Congenit Anom (Kyoto). 2009 Jun;49(2):47-55
pubmed: 19489954
JAMA Psychiatry. 2019 Jun 1;76(6):594-602
pubmed: 30840048
PLoS One. 2012;7(11):e49700
pubmed: 23209593
J Virol. 1996 Nov;70(11):7398-413
pubmed: 8892858
Teratology. 2000 Aug;62(2):79-85
pubmed: 10931504
Arch Virol. 1995;140(10):1725-36
pubmed: 7503674